-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Initiates Coverage On vTv Therapeutics with Buy Rating, Announces Price Target of $67

Benzinga·01/05/2026 12:48:57
语音播报
TD Cowen analyst Ritu Baral initiates coverage on vTv Therapeutics (NASDAQ:VTVT) with a Buy rating and announces Price Target of $67.